Thrombus Aspiration Before Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial Infarction The DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) Study by Silva-Orrego, Pedro et al.
CT
P
R
T
A
P
A
A
M
I
b
t
m
s
b
w
c
a
e
M
M
U
2
Journal of the American College of Cardiology Vol. 48, No. 8, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
PLINICAL RESEARCH Interventional Cardiology
hrombus Aspiration Before
rimary Angioplasty Improves Myocardial
eperfusion in Acute Myocardial Infarction
he DEAR-MI (Dethrombosis to Enhance
cute Reperfusion in Myocardial Infarction) Study
edro Silva-Orrego, MD,* Paola Colombo, MD, PHD,* Riccardo Bigi, MD,† Dario Gregori, MA, PHD,‡
nabella Delgado, MD,* Paolo Salvade, MD,* Jacopo Oreglia, MD,* Paola Orrico, RN,*
nna de Biase, MD,* Giacomo Piccalò, MD,* Irene Bossi, MD,* Silvio Klugmann, MD*
ilan and Turin, Italy
OBJECTIVES This study sought to test the hypothesis that thrombus removal, with a new manual
thrombus-aspirating device, before primary percutaneous coronary intervention (PPCI) may
improve myocardial reperfusion compared with standard PPCI in patients with ST-segment
elevation acute myocardial infarction (STEMI).
BACKGROUND In STEMI patients, PPCI may cause thrombus dislodgment and impaired microcirculatory
reperfusion. Controversial results have been reported with different systems of distal
protection or thrombus removal.
METHODS One-hundred forty-eight consecutive STEMI patients, admitted within 12 h of symptom
onset and scheduled for PPCI, were randomly assigned to PPCI (group 1) or manual
thrombus aspiration before standard PPCI (group 2). Patients with cardiogenic shock,
previous infarction, or thrombolytic therapy were excluded. Primary end points were complete
(70%) ST-segment resolution (STR) and myocardial blush grade (MBG) 3.
RESULTS Baseline clinical and angiographic characteristics were similar in the 2 groups. Comparing
groups 1 and 2: complete STR 50% versus 68% (p  0.05); MBG-3 44% versus 88% (p 
0.0001); coronary Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 78% versus
89% (p NS); corrected TIMI frame count 21.5 12 versus 17.3 6 (p 0.01); no reflow
15% versus 3% (p  0.05); angiographic embolization 19% versus 5% (p  0.05); direct
stenting 24% versus 70% (p  0.0001); and peak creatine kinase-mass band fraction 910 
128 g/l versus 790  132 g/l (p  0001). In-hospital clinical events were similar in the 2
groups. After adjusting for confounding factors, multivariate analysis showed thrombus
aspiration to be an independent predictor of complete STR and MBG-3.
CONCLUSIONS Manual thrombus aspiration before PPCI leads to better myocardial reperfusion and is
associated with lower creatine kinase mass band fraction release, lower risk of distal
embolization, and no reflow compared with standard PPCI. (Thrombus Aspiration Before
Standard Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial
Infarction; http://clinicaltrials.gov/ct/show/NCT00257153). (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.0681552–9) © 2006 by the American College of Cardiology Foundation
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an the last few years, mechanical reperfusion has proven to
e a superior treatment strategy compared with systemic
hrombolysis in patients with ST-segment elevation acute
yocardial infarction (STEMI) (1). In addition, several
tudies suggest that better short- and long-term results can
e obtained with additional stenting and abciximab (2–5),
hich are part of standard STEMI treatment in most
enters. Nevertheless, the presence of a large thrombus load
t the lesion site may provide an increased risk of distal
mbolization of thrombotic or plaque material during bal-
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edicine, Milan, Italy; and the ‡Department of Public Health and Microbiology,
niversity of Turin, Turin, Italy.c
Manuscript received December 2, 2005; revised manuscript received March 7,
006, accepted March 7, 2006.oon inflation or stent deployment (6–12), with possible
eduction of distal flow or no reflow and further infarct
xtension. Angiographic evidence of distal embolization in
atients treated with primary angioplasty (PPCI) occurs in
bout 15% of patients and is associated with more extensive
yocardial damage and worse outcome (12).
Restoration of normal flow in the epicardial infarct-
elated artery (IRA) is not always indicative of myocardial
alvage (13,14). Even in the presence of normal epicardial
ow, impaired myocardial perfusion assessed with contrast
chocardiography (15,16) or angiographic myocardial blush
rade (MBG) (14,17) after PPCI is associated with poor
ecovery of ventricular function and is an independent
redictor of long-term mortality. On the other hand,
lthough the resolution of ST-segment elevation (STR)
orrelates with IRA patency (18), its absence does not
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October 17, 2006:1552–9 Thrombus Aspiration in Acute MIredict an occluded artery (19). However, several studies
uggest that STR failure indicates inadequate myocardial
eperfusion and is associated with poor recovery of left
entricular function and increased mortality, even in the
resence of patent IRA (18,20–24). In recent years, con-
roversial results on myocardial reperfusion have been re-
orted with different strategies of mechanical distal protec-
ion or thrombus removal (25–30). This study was designed
o test the hypothesis that thrombus aspiration before
tandard PPCI may improve myocardial reperfusion as
ompared with the standard procedure.
ETHODS
atient population. Between March 2004 and June 2005,
60 consecutive STEMI patients undergoing primary an-
ioplasty within 12 h of symptom onset were randomized to
tandard PPCI, including stenting and abciximab, or
hrombus aspiration before standard PPCI. Inclusion crite-
ia were continuous chest pain 30 min, ST-segment
levation 0.1 mV (0.2 mV in case of anterior leads) in 3
ontiguous leads on a 12-lead electrocardiogram (ECG),
nd technical feasibility for primary angioplasty indepen-
ently of initial Thrombolysis In Myocardial Infarction
Abbreviations and Acronyms
CI  confidence interval
CK-MB  creatine kinase mass band fraction
ECG  electrocardiogram
IRA  infarct-related artery
MBG  myocardial blush grade
PPCI  primary percutaneous coronary intervention
STmax  maximal ST-segment elevation
STEMI  ST-segment elevation acute myocardial
infarction
STR  ST-segment resolution
TIMI  Thrombolysis In Myocardial Infarctionigure 1. The dual-lumen extraction catheter (Pronto) with the proximal lockingTIMI) flow or angiographic evidence of intraluminal
hrombus in the culprit artery. Exclusion criteria were
ardiogenic shock, previous myocardial infarction or coro-
ary bypass surgery, bundle branch block or pacemaker-
nduced rhythm on admission ECG, and contraindication
o glycoprotein IIb/IIIa inhibitors.
The study protocol was approved by the local ethics
ommittee, and informed consent was obtained from all
atients.
rocedure and device description. After enrollment, pa-
ients were 1:1 randomly assigned to standard angioplasty
ith stenting and abciximab (group 1) or thrombus aspira-
ion plus standard angioplasty (group 2).
Thrombus aspiration was performed using the Pronto ex-
raction catheter (Vasc.solutions, Minneapolis, Minnesota).
he device (Fig. 1) is a simple, dual-lumen, monorail design,
-F compatible catheter. The smaller lumen is to accom-
odate a standard 0.014-inch guidewire. The larger extrac-
ion lumen allows the removal of thrombus, which is
spirated with a 30-ml locking vacuum syringe. The cath-
ter has a rounded distal tip designed to maximize thrombus
spiration and to protect the vessel wall while advancing and
uring aspiration.
After crossing the culprit lesion with a standard guide-
ire, several passages across the lesion were performed by
lowly advancing the catheter. Predilatation was performed
ith a 2-mm balloon catheter only when the initial attempt
ailed to cross the lesion. Subsequently, direct stenting was
ecommended to all patients. Before intervention, all pa-
ients received aspirin and heparin (60 U/kg). Glycoprotein
Ib/IIIa inhibitors were used in all patients before the
rocedure.
ngiographic analysis. Coronary angiograms were per-
ormed using a digital technique (Integris 3000, Philips
edical Systems, Best, the Netherlands). At least 2 orthog-
nal projections of the coronary segment scheduled for
oronary intervention were filmed before and after thevacuum syringe (A) and the tip of the device (B); see text for explanations.
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Thrombus Aspiration in Acute MI October 17, 2006:1552–9ntervention. Each angiogram was preceded by intracoro-
ary injection of nitrates (Nitroglycerin 100 to 200 g).
uantitative coronary analysis was performed using the
oronary Quantification Package (Philips Medical Systems,
indhoven, the Netherlands). At least 1 film after complete
reatment included the myocardial territory of contrast
istribution to allow estimation of TIMI flow (23-inch
eld) and MBG (23-inch field). Views were chosen to
inimize superimposition of noninfarcted territories in the
ssessment of the MBG: laterolateral view for the left
nterior descending coronary, right anterior oblique 45°
iew for the right coronary artery, and laterolateral or right
nterior oblique 45° (in the presence of big marginal branch)
iews for the circumflex artery were used in most cases. The
uration of cine filming was long enough to see some filling
f the venous system to evaluate the washout phase of
ontrast dye. To facilitate the subjective grading of MBG,
ngiograms were digitized and a logarithmic nonmagnified
ask-mode background substraction was applied to the
mage subset to eliminate noncontrast medium densities.
inal analysis of TIMI flow grade, corrected TIMI frame
ount, and MBG was carried out by 2 experienced cardiol-
gists (P.C. and P.S.) who were blinded to the study
atabase, according to standard methods (14,31,32).
Coronary TIMI flow and MBG of 50 qualifying angio-
rams were analyzed, and both observers categorized the
IMI flow grade into TIMI 3, 2, and 0/1 and the MBG
nto 3, 2, and 0/1. The interobserver agreement was
alculated with weighted k statistics, which resulted in a k
alue of 0.91 (95% confidence interval [CI] 0.78 to 1.03) for
IMI flow and 0.85 (95% CI 0.70 to 0.99) for MBG.
isagreement was resolved by consensus.
lectrocardiographic analysis. A 12-lead ECG was re-
orded at admission, at the end of the procedure, and at 90
in and 24 h after the procedure. Two observers blinded to
andomization and angiographic results analyzed ECG
ecordings. The ST score, defined as the sum of ST-
egment elevation measured at 20 ms from the J-point in
he leads V1 to V6, I, and aVL for anterior and D2, D3, aVF,
nd V5 to V6 for nonanterior infarctions, as well as maximal
T-segment (STmax) elevation in the worst single lead
ere calculated in all patients. Reciprocal changes of ST-
egment depression were not considered. Percent ST score
nd STmax resolution was calculated from admission and
ost-PPCI ECG and categorized as complete (70%),
artial (30% to 70%) and no reperfusion (30%), as
reviously suggested (18). Interobserver agreement in ECG
eading was evaluated by k statistics in 50 admission and
ost-PPCI ECGs: k value was 0.90 (95% CI 0.77 to 1.03).
isagreement was resolved by consensus.
nzymatic infarct size. Infarct size was estimated by
easurement of enzyme activity by using creatine kinase
ass band fraction (CK-MB) as a reference. The enzymatic
ctivity was reported as g/l, and was assessed every 6 h in
he first 48 h after admission. Peak release value from 8
erial measurements up to 48 h after admission is reported. dtudy end points. The primary end point of this study was
he achievement of myocardial reperfusion, defined by
ostprocedural complete (70%) ST-segment resolution
nd post-PPCI MBG-3. Prespecified secondary end points
ere the comparison between the incidence of angiographic
istal embolization and no reflow, peak of CK-MB release,
nd direct stenting in the 2 groups. Information on the
n-hospital and 30-day occurrence of adverse events includ-
ng death, nonfatal reinfarction, new hospitalization for
eart failure, target vessel revascularization, stroke, and
ajor bleedings was also collected.
efinitions. Cardiogenic shock was defined as hypoten-
ion with systolic blood pressure 90 mm Hg and tachy-
ardia 100 beats/min, not caused by hypovolemia and
equiring inotropic support or balloon counterpulsation.
Technical success of thrombectomy (device success) was
efined as the ability of the device to cross the target lesion
nd to increase TIMI flow by 1.
Procedural success of the intervention was defined by the
chievement of a final TIMI flow grade 2 and a residual
tenosis 20%.
The diagnosis of reinfarction was supported by either
CG changes (new onset, significant Q waves in at least 2
CG leads, recurrent or increased ST-segment elevation in
he previous infarct leads, or new-onset ST-segment eleva-
ion in different ECG leads) accompanied by 30 min
hest pain or cardiac enzyme release (CK-MB 50%
bove the prior level) occurring 24 h after coronary
evascularization.
Distal embolization was defined as the migration of a
lling defect or the distal occlusion of the target vessel or
ne of its branches at the end of or during the procedure.
No reflow was defined as a TIMI flow grade 2 not
ttributable to dissection, occlusive thrombosis, or epicardial
pasm.
tatistical analysis. The target sample size was calculated on
n assumption of a 30% improvement in the ST reduction in
he study arm considering a 50% complete ST-segment reso-
ution in the control arm (13,24,33). We estimated that 75
atients would be required in each group to have a power of
0% to detect an absolute difference in the occurrence of
omplete ST-segment resolution with a 2-sided alpha value
f 0.05. Considering a 10% drop-out or lose to lecture, we
lanned to enroll a total of 160 patients. All analyses were
erformed according to the intention-to-treat principle.
ategorical variables are presented as frequency values and
ere compared by chi-square test. Continuous variables are
xpressed as mean values  SD, and were compared with
tudent t test or analysis of variance as appropriate. Step-
ise logistic regression analysis was performed to identify
he independent predictors of MBG-3 and complete ST-
egment resolution after the procedure. The following
ariables were entered into model: age 65 years, hyper-
ension, diabetes, infarct location, Killip class 2, ischemic
ime (from symptom onset to wire crossing), procedure
uration (from arrival to the angiographic room to last
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October 17, 2006:1552–9 Thrombus Aspiration in Acute MIngiogram), heart rate at admission, multivessel disease,
ccluded IRA at baseline (TIMI 0/1), angiographic evi-
ence of thrombus, presence of collaterals, direct stenting,
nd use of aspiration catheter.
A value of p  0.05 was interpreted as statistically
ignificant. Statistical analysis was performed using SPSS
able 1. Baseline Clinical and Angiographic Characteristics
Thrombus
Removal
No Thrombus
Removal p Value
atients, n 74 74
ge (yrs) 57.3  13 58.9  14 0.472
ale gender 62 (84%) 56 (76%) 0.314
iabetes 16 (21%) 11 (15%) 0.465
ypertension 28 (37%) 32 (46%) 0.349
yslipidemia 26 (34%) 18 (25%) 0.309
moking habit 38 (54%) 43 (60%) 0.571
illip class 1 8 (11%) 4 (5%) 0.297
nterior infarction 32 (42%) 38 (51%) 0.355
jection fraction 53  7% 51  9% 0.133
schemic time (min) 206  115 199  124 0.722
arget vessel
LAD 32 (43%) 38 (51%) 0.420
LCX 7 (10%) 10 (14%) 0.623
RCA 35 (47%) 26 (35%) 0.191
AD extension
1 vessel 36 (49%) 36 (49%) 0.876
2 vessels 23 (31%) 24 (32%) 0.965
3 vessels 15 (20%) 14 (19%) 0.958
IMI flow grade
0/1 60 (81%) 54 (73%) 0.657
2 12 (16%) 16 (22%) 0.646
3 2 (3%) 4 (5%) 0.822
AD  coronary artery disease; LAD  left anterior descending coronary artery;
CX  left circumflex coronary artery; RCA  right coronary artery; TIMI 
hrombolysis In Myocardial Infarction.
Table 2. Procedural Data and Angiographic R
Thro
Patients, n
Glycoprotein IIb/IIIa inhibitors
Stenting
Direct stenting
Stent length (mm) 2
Reference diameter post-PPCI (mm)
Minimal lumen diameter post-PPCI (mm)
% vessel stenosis post-PPCI 0
TIMI flow grade pre-PPCI 0
TIMI flow grade post-PPCI 2
TIMI flow grade 3 post-PPCI
Corrected TIMI frame count post-PPCI 1
Procedural time (min)
Procedural success
Device success
Myocardial blush grade post-PPCI
0/1
2
3
Distal embolization
No reflow
Peak CK-MB 7CK-MB  creatinine kinase-mass band fraction; PPCI  primary
In Myocardial Infarction.1.0 (SPSS Inc., Chicago, Illinois) and S-plus (release
000) statistical package (Insightful Corporation, Seattle,
ashington) and the Harrell’s Design and Hmisc libraries
ere used for analysis.
The authors had full access to the data and take respon-
ibility for its integrity. All authors have read and agree to
he manuscript as written.
ESULTS
welve (12.5%) of the 160 patients who were initially
nrolled were dropped out because of protocol reasons
nknown at the moment of randomization (need for coro-
ary surgery in 6, previous infarction in 2, previous angio-
lasty with stenting in 1, distal embolization on the basal
ngiogram in 1, no significant ST-segment deviation in 1,
nd cardiogenic shock in 1). Thus, the final population
onsisted of 148 patients who were allocated to the 2
reatment groups. In 7 of the 74 patients assigned to group
, aspiration was not performed because of technical rea-
ons, whereas 3 of the 74 patients assigned to standard PCI
nderwent aspiration to remove residual thrombus after
tenting. There were no significant differences in baseline
linical and angiographic characteristics between the 2
roups (Table 1).
rocedural data and angiographic analysis. Procedural
ata are reported in Table 2. All patients received glyco-
rotein IIb/IIIa inhibitors, and a stent was positioned in all
ut 3 patients (2 in the control and 1 in the aspirated group).
n case of multivessel coronary artery disease, only the
ulprit vessel was treated during the initial PPCI. Stent
ength, number of stents per patient, and stent/vessel ratio
Removal No Thrombus Removal p Value
4 74
0 100 —
%) 72 (97%) —
%) 18 (24%) 0.0001
8.7 20.9  9.5 0.841
0.46 3.2  0.43 0.174
0.41 3.1  0.61 0.020
1.64 1.3  8.49 0.307
0.86 0.71  0.99 0.214
0.36 2.68  0.5 0.008
%) 58 (78%) 0.119
6 21.5  12 0.007
19 54  21 0.363
0%) 73 (99%) 0.767
%) — —
) 5 (6%) 0.098
%) 37 (50%) 0.0001
%) 32 (44%) 0.0001
) 14 (19%) 0.019
) 11 (15%) 0.024
132 910  128 0.0001esults
mbus
7
10
73 (99
52 (70
1.1 
3.3 
3.3 
.27 
.52 
.87 
66 (89
7.3 
57 
74 (10
66 (89
0 (0%
9 (12
65 (88
4 (5%
2 (3%
90 percutaneous coronary intervention; TIMI  Thrombolysis
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Thrombus Aspiration in Acute MI October 17, 2006:1552–9ere similar between both groups. Procedural success was
btained in all patients with thrombus aspiration and in 73
99%) of the 74 patients treated with standard PPCI.
ostprocedural percent stenosis, minimal luminal diameter,
nd reference vessel diameter were similar in the 2 groups.
tent implantation without predilation was possible in 70%
f patients with thrombus aspiration and in 24% of those
ith standard PCI (p  0.0001).
hrombus aspiration. Technical success of thrombectomy
as observed in 89% of patients assigned to thrombus
spiration (Table 2). Failure was caused by the impossibility
f crossing the target lesion because of iliac or coronary
ortuosity, tight lesion, or both in 7 and no change in TIMI
ow after aspiration in 1 patient.
After aspiration, TIMI flow grade increased from 0.5 
.86 to 2.87  0.36 (p  0.01). Final TIMI flow and
orrected TIMI frame count significantly improved in
atients with thrombus removal in comparison with stan-
ard PCI: 2.87  0.36 frames versus 2.68  0.5 frames
p  0.01); and 17.3  6 frames versus 21.5  12 frames
p  0.01), respectively. In particular, TIMI flow increased
igure 2. Coronary angiogram in acute anterior myocardial infarction. The
LAD) with thrombus image bulging into the left main artery (arrow). Af
he mid-LAD more than 20 mm distal to the original occlusion site.
Table 3. Electrocardiographic Analysis
Patients, n
ST-segment score pre-PPCI (mm)
ST-segment score post-PPCI (mm)
ST-segment resolution score
Complete (70%)
Partial (30–70%)
None (30%)
Maximum ST-segment elevation pre-PPCI (mm)
Maximum ST-segment elevation post-PPCI (mm)
Maximum ST-segment resolution
Complete (70%)
Partial (30–70%)
None (30%)PPCI  primary percutaneous coronary intervention.y 1 grade in 17.6% versus 20.2% (p  NS), by 2 grades in
1.6% versus 28.4% (p  NS), and by 3 grades in 58.1%
ersus 39.2% (p  0.05) of patients. One patient from each
reatment group showed persistent TIMI flow grade 1 after
he procedure, whereas no patient showed persistent TIMI
ow grade 0. In 20% of patients, after thrombus removal,
he culprit lesion was located distal to the initial occlusion
ite, in some cases more than 20 mm, changing the technical
pproach to the procedure (Fig. 2). Macroscopic aspirated
aterial was observed in 70 of 74 (95%) patients. Angio-
raphic transient no reflow and distal embolization were
ignificantly less frequent in group 2 than in group 1: 3%
ersus 15% (p  0.05) and 5% versus 19% (p  0.05),
espectively. Coronary perforation or intimal dissection
ere not observed.
yocardial reperfusion. The ECG results are reported
n Table 3. Complete ST-segment resolution (70%)
as significantly more frequent in group 2 than in group
evaluated as score (68% vs. 50%, p  0.05) or STmax
68% vs. 50%, p  0.05). By multivariate analysis,
hrombus removal was independently associated with
angiogram (A) shows total occlusion of the left anterior descending artery
rombus removal (B and C), the culprit lesion (arrowheads) is observed in
Thrombus
Removal
No Thrombus
Removal p Value
74 74
13.75  10.37 12.60  8.9 0.470
3.98  5.17 4.88  5.3 0.297
50 (68%) 37 (50%) 0.043
21 (28%) 26 (35%) 0.639
3 (4%) 11 (15%) 0.046
4.6  2.71 4.52  2.52 0.852
1.45  1.69 1.68  1.72 0.413
50 (68%) 37 (50%) 0.041
21 (28%) 27 (36%) 0.388
3 (4%) 10 (13%) 0.096basal
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October 17, 2006:1552–9 Thrombus Aspiration in Acute MIT-segment resolution considered as score (odds ratio
.77, 95% CI 0.89 to 3.52) or STmax (odds ratio 2.11,
5% CI 1.03 to 4.3).
The MBG was significantly higher among patients
reated with thrombus aspiration compared with conven-
ional PCI: 2.84  0.32 versus 2.38  0.59 (p  0.001). In
articular, final MBG-3 was observed in 88% versus 44%
p  0.0001), respectively, in the 2 groups.
After adjusting for potentially confounding covariates,
ultivariate analysis showed thrombus aspiration (odds
atio 15.37, 95% CI 5.49 to 43) and the duration of the
rocedure (odds ratio 0.31, 95% CI 0.16 to 0.60) to be the
nly independent predictors of MBG-3.
The peak CK-MB release was significantly lower in
atients with thrombus removal compared with the control
roup: 790  132 g/l vs. 910  128 g/l (p  0.0001).
linical outcomes. In-hospital occurrence of death, re-
nfarction, left ventricular failure, and new revasculariza-
ion were similar in the 2 groups. No death or reinfarc-
ion was observed during the hospital stay. In the
hrombus aspiration group, 1 patient needed a new PCI
f the target vessel. In the control group, 1 patient had
eft ventricular failure.
ISCUSSION
hrombus removal, epicardial flow, and myocardial
eperfusion. Currently, PPCI with stent and abciximab is
onsidered the treatment of choice in patients with acute
yocardial infarction (1–3). However, myocardial reperfu-
ion assessed with angiographic (14) and electrocardio-
raphic (34) parameters is not always achieved. Thrombus
nd plaque embolization is one of the mechanisms affecting
yocardial reperfusion by inducing capillary obstruction,
ndothelial dysfunction, and inflammation (35,36) and is
ssociated with a poor long-term outcome (12).
The present randomized study included all consecutive
atients with STEMI presenting within 12 h from symp-
om onset independently of the angiographic evidence of
hrombus, assuming that thrombus is always present in a
ecent myocardial infarction. Cardiogenic shock, previous
nfarction, and bypass surgery were regarded as exclusion
riteria to minimize the risk of misinterpretation in the
ssessment of angiographic reperfusion. The main finding
as that thrombus aspiration was associated with a better
picardial flow, significant improvement of myocardial
eperfusion, and reduction of peak CK-MB release. In
ddition, it conveyed a significantly lower risk of distal
mbolization and no reflow. Thus, it seems that effective
hrombus removal by manual aspiration at the lesion site
mproves myocardial reperfusion by reducing distal embo-
ization occurring during mechanical revascularization. We
reviously found (37) severe and diffuse coronary flow
mpairment after stenting in patients treated with PPCI
espite the use of distal protection with a filter. This may tuggest a role of humoral mediators released from the
hrombus during stenting.
echnical changes during angioplasty. In keeping with
revious reports (25–27), the present study shows that
hrombus removal allows direct stenting in a significantly
igher proportion of patients. The higher rate of direct
tenting could have played a role in the reperfusion benefit
bserved in the aspirated group. However, the multivariate
nalysis showed thrombus aspiration, but not direct stent-
ng, to be independently associated with reperfusion. Direct
tenting avoids unnecessary manipulation of the lesion and
iminishes the use of balloons. In addition, the culprit
esion was located distally to the initial occlusion site in
0% of patients treated with thrombus removal. When
he initial occlusion is at an important bifurcation site
Fig. 2), thrombus removal may avoid acute complications
nd improve the long-term result.
Although the aspirated thrombus was very proximal to
he lesion and direct stenting should result in shorter stent
overage in many cases, we did not observe a significant
ifference in stent length between the 2 groups. This likely
ould be explained by the common approach to the proce-
ure, which included a full coverage of the lesion starting
rom the occlusion site.
Differently from other studies with distal protection using
he GuardWire (Medtronic Corp., Santa Rosa, California)
28) or thrombus removal with X-Sizer (ev-3, White Bear
ake, Minnesota) (26), which included an additional pro-
edural time of 10 to 20 minutes, the duration of the
rocedure was similar in the 2 groups of our study.
omparison with other studies. In the present study, the
ate of MBG-3 (88%) and complete ST-segment resolu-
ion (68%) after thrombus removal was higher compared
ith previous reports on conventional angioplasty
14,24). A large multicenter randomized trial with a
istal balloon occlusion and aspiration system (28)
howed that distal protection and retrieval of embolic
ebris did not result in improvement of myocardial
eperfusion or infarct size. Other recent randomized trials
omparing thrombectomy with the X-Sizer device and
onventional angioplasty have shown a higher rate of
BG-3 and 50% ST-segment resolution in patients
reated with thrombus removal (25,26). Two randomized
tudies using AngioJet (POSSIS Medical Inc., Minne-
polis, Minnesota) have shown controversial results in
yocardial reperfusion and infarct size reduction (29,30).
ifferences in patient selection (inclusion of patients
ith previous infarction, bypass surgery, or treatment
ith fibrinolytic agents), procedural duration, and type of
evice could explain in part these discrepancies. More
ecently, Burzotta et al. (27) reported the results of a
andomized trial on thrombus removal versus conven-
ional angioplasty with a different manual aspiration
ystem in patients with STEMI. They found a significant
mprovement in complete (70%) ST-segment resolu-
ion (58% vs. 36%) and MBG 2 (68% vs. 45%). The
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tudy could be explained, at least in part, by differences in
atient selection. In fact, although the angiographic
vidence of thrombus was not an inclusion/exclusion
riteria in both studies, patients with previous infarction,
ardiogenic shock, and previous thrombolysis were not in-
luded in our study, although they account for 30% of
atients in the REMEDIA (Randomized Evaluation of the
ffect of Mechanical Reduction of Distal Embolization by
hrombus Aspiration in Primary and Rescue Angioplasty)
rial (27).
tudy limitations. The study reflects a single-center expe-
ience and was not designed to test differences in clinical
utcome. In fact, it dealt with a low-risk population with a
hort follow-up period and no in-hospital mortality. An-
ther limitation is that the study did not include the entire
TEMI population, particularly patients with shock, previ-
us infarction, bypass surgery, or previous treatment with
brinolytic agents.
onclusions. In selected patients, thrombus aspiration
ith the Pronto catheter in the setting of primary angio-
lasty is a simple and safe procedure. It improves myocardial
eperfusion as assessed by myocardial blush and ST-
egment resolution. It is associated with a lower CK-MB
elease and a lower rate of distal embolization and no reflow.
arger randomized trials are warranted to address the
mpact of thrombus removal on clinical outcome.
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